Market Research Logo

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Liver Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Liver Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Liver Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Liver Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Liver Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
4 Liver Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Liver Cancer Companies - Pipeline Products by Stage of Development
4.2 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Liver Cancer Diagnostic Tests Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Abcodia Ltd. Company Overview
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.3 AXO Science S.A.S. Company Overview
5.3.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
5.4 BioMark Technologies Inc. Company Overview
5.4.1 BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 China Sky One Medical, Inc. Company Overview
5.5.1 China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Digna Biotech, S.L. Company Overview
5.6.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Drexel University Company Overview
5.7.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
5.8 German Cancer Research Center Company Overview
5.8.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.9 Glycotest, Inc. Company Overview
5.9.1 Glycotest, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Imperial College London Company Overview
5.10.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.11 IntegraGen SA Company Overview
5.11.1 IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
5.12 Matrix-Bio, Inc. Company Overview
5.12.1 Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 NanoString Technologies, Inc. Company Overview
5.13.1 NanoString Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 National Cancer Institute Company Overview
5.14.1 National Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
5.15 Oncimmune (USA) LLC Company Overview
5.15.1 Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Orion Genomics LLC Company Overview
5.16.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 PleX Diagnostics Company Overview
5.17.1 PleX Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.18 ProMIS Neurosciences Inc. Company Overview
5.18.1 ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.19 Proplex Technologies, Llc Company Overview
5.19.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Proteome Sciences Plc Company Overview
5.20.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Roche Diagnostics International Ltd. Company Overview
5.21.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.22 TrovaGene, Inc. Company Overview
5.22.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of Rochester Company Overview
5.23.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.24 Ventana Medical Systems, Inc. Company Overview
5.24.1 Ventana Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.25 Viomics Inc. Company Overview
5.25.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.26 XEPTAGEN SpA Company Overview
5.26.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
5.27 Xiamen Zeesan Biotech Co.,Ltd Company Overview
5.27.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Liver Cancer Diagnostic Tests - Recent Developments
6.1 Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results
6.2 Aug 09, 2016: Blueprint Medicines Reports Second Quarter 2016 Financial Results
6.3 Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments
6.4 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016
6.5 Aug 03, 2016: NanoString Technologies Releases Operating Results for Second Quarter of 2016
6.6 Aug 02, 2016: Pfizer Reports Second-Quarter 2016 Results
6.7 Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors
6.8 Jul 13, 2016: Pfizer and NovaMedica announce a strategic partnership in Russia
6.9 Jul 12, 2016: PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026
6.10 Jul 07, 2016: IntegraGen reports strong revenue growth during first half of 2016
6.11 Jul 04, 2016: Oncimmune Enters into Research Agreement with Egybiotech and Aarhus University Hospital
6.12 Jun 27, 2016: ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units
6.13 Jun 23, 2016: Oncimmune Appoints Julian Hirst as Non-Executive Director
6.14 Jun 16, 2016: Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts
6.15 Jun 02, 2016: NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
6.16 Jun 01, 2016: Royal Philips Enters into Research Agreement with Yale School of Medicine
6.17 Jun 01, 2016: Proteome Sciences Announces CEO Appointment
6.18 May 31, 2016: Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018
6.19 May 31, 2016: Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019
6.20 May 31, 2016: Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021
6.21 May 31, 2016: Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026
6.22 May 31, 2016: Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044
6.23 May 11, 2016: ProMIS Neurosciences announces first quarter 2016 results
6.24 May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results
6.25 May 10, 2016: Blueprint Medicines Reports First Quarter 2016 Financial Results
6.26 Apr 27, 2016: A.G. Schneiderman Announces Multistate And Federal Settlement With Wyeth And Pfizer For $784.6m To Resolve Allegations Of Underpaying Rebates Owed Through The Medicaid Drug Rebate Program
6.27 Mar 07, 2016: Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems
6.28 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing
6.29 Oct 27, 2015: Simple blood test measures risk of liver cancer
6.30 Sep 21, 2015: Veran Medical Raises USD30.6 Million in Venture Financing
6.31 Sep 09, 2015: Quirem Medical Raises Funds through Private Placement of Shares
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Liver Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 6: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: ARCHITECT c16000 System - PIVKA Assay - Product Status
Table 9: ARCHITECT c16000 System - PIVKA Assay - Product Description
Table 10: ARCHITECT c4000 System - PIVKA Assay - Product Status
Table 11: ARCHITECT c4000 System - PIVKA Assay - Product Description
Table 12: ARCHITECT c8000 System - PIVKA Assay - Product Status
Table 13: ARCHITECT c8000 System - PIVKA Assay - Product Description
Table 14: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Status
Table 15: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Description
Table 16: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Status
Table 17: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Description
Table 18: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Status
Table 19: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Description
Table 20: Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Biomarker Test - Liver Cancer - Product Status
Table 22: Biomarker Test - Liver Cancer - Product Description
Table 23: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Multiplexed Detection - Des-Carboxy Prothrombin - Product Status
Table 25: Multiplexed Detection - Des-Carboxy Prothrombin - Product Description
Table 26: Multiplexed Detection - Matrix metalloproteinase 1 - Product Status
Table 27: Multiplexed Detection - Matrix metalloproteinase 1 - Product Description
Table 28: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Status
Table 29: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Description
Table 30: BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Biomarker Assay - Hepatocellular Cancer - Product Status
Table 32: Biomarker Assay - Hepatocellular Cancer - Product Description
Table 33: China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Kit - Liver Cancer - Product Status
Table 35: Diagnostic Kit - Liver Cancer - Product Description
Table 36: Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: HCC Molecular Marker Assay - Product Status
Table 38: HCC Molecular Marker Assay - Product Description
Table 39: Oxidated APO-A1 Assay - Product Status
Table 40: Oxidated APO-A1 Assay - Product Description
Table 41: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Diagnostic Test - Liver Cancer - Product Status
Table 43: Diagnostic Test - Liver Cancer - Product Description
Table 44: Glycan-Based Biomarker Assay - Liver Cancer - Product Status
Table 45: Glycan-Based Biomarker Assay - Liver Cancer - Product Description
Table 46: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 47: RAGE Based Diagnostic Assay - Liver Cancer - Product Status
Table 48: RAGE Based Diagnostic Assay - Liver Cancer - Product Description
Table 49: Glycotest, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Diagnostic Test - Liver Cancer - Product Status
Table 51: Diagnostic Test - Liver Cancer - Product Description
Table 52: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Diagnostic Assay - HCC - Product Status
Table 54: Diagnostic Assay - HCC - Product Description
Table 55: IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
Table 56: CLIA Test - Hepatocellular Carcinoma - Product Status
Table 57: CLIA Test - Hepatocellular Carcinoma - Product Description
Table 58: Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 59: VeraMarker LCS (Liver Cancer Screening) Test - Product Status
Table 60: VeraMarker LCS (Liver Cancer Screening) Test - Product Description
Table 61: VeraMarker Liver Cancer Screening Test - Hepatitis - Product Status
Table 62: VeraMarker Liver Cancer Screening Test - Hepatitis - Product Description
Table 63: NanoString Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 64: In Vitro Diagnostic Assay - HCC Gene Signature - Product Status
Table 65: In Vitro Diagnostic Assay - HCC Gene Signature - Product Description
Table 66: National Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 67: HCC Gene Signature Diagnostic Test - Product Status
Table 68: HCC Gene Signature Diagnostic Test - Product Description
Table 69: HCC Gene Signature Prognostic Test - Product Status
Table 70: HCC Gene Signature Prognostic Test - Product Description
Table 71: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 72: EarlyCDT - Liver Cancer - Product Status
Table 73: EarlyCDT - Liver Cancer - Product Description
Table 74: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Diagnostic Assay - Liver Cancer - Product Status
Table 76: Diagnostic Assay - Liver Cancer - Product Description
Table 77: PleX Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 78: HCCpleX - Product Status
Table 79: HCCpleX - Product Description
Table 80: ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Screening Test - Liver Cancer - Product Status
Table 82: Screening Test - Liver Cancer - Product Description
Table 83: Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Biomarker Diagnostic Test - Liver Cancer - Product Status
Table 85: Biomarker Diagnostic Test - Liver Cancer - Product Description
Table 86: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Biomarker Assay - Liver Cancer - Product Status
Table 88: Biomarker Assay - Liver Cancer - Product Description
Table 89: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Glypican-3 MAb Companion Diagnostic Test - Product Status
Table 91: Glypican-3 MAb Companion Diagnostic Test - Product Description
Table 92: TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Diagnostic Test - Liver Cancer - Product Status
Table 94: Diagnostic Test - Liver Cancer - Product Description
Table 95: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Biomarker Test - HCC - Product Status
Table 97: Biomarker Test - HCC - Product Description
Table 98: Ventana Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 99: BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma - Product Status
Table 100: BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma - Product Description
Table 101: Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Diagnostic Assay - Liver Cancer - Product Status
Table 103: Diagnostic Assay - Liver Cancer - Product Description
Table 104: XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 105: compleXima HCC Biochip - Liver Cancer - Product Status
Table 106: compleXima HCC Biochip - Liver Cancer - Product Description
Table 107: DCP-IgM Kit - Liver Cancer - Product Status
Table 108: DCP-IgM Kit - Liver Cancer - Product Description
Table 109: GPC3-IgM Kit - Liver Cancer - Product Status
Table 110: GPC3-IgM Kit - Liver Cancer - Product Description
Table 111: Osteopontin-IgM Kit - Liver Cancer - Product Status
Table 112: Osteopontin-IgM Kit - Liver Cancer - Product Description
Table 113: Survivin-IgM Kit - Liver Cancer - Product Status
Table 114: Survivin-IgM Kit - Liver Cancer - Product Description
Table 115: VEGF-IgM Kit - Liver Cancer - Product Status
Table 116: VEGF-IgM Kit - Liver Cancer - Product Description
Table 117: Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Theranostic - Liver Cancer Metastasis - Product Status
Table 119: Theranostic - Liver Cancer Metastasis - Product Description
Table 120: Glossary
1.2 List of Figures
Figure 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report